Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates

Int J Antimicrob Agents. 2004 Dec;24(6):585-91. doi: 10.1016/j.ijantimicag.2004.08.008.

Abstract

In vitro susceptibility to 15 beta-lactam antibiotics was evaluated using Enterobacteriaceae isolated during the SENTRY Antimicrobial Surveillance Program. Piperacillin/tazobactam was the most active penicillin against Escherichia coli, Proteus mirabilis, Klebsiella oxytoca and Klebsiella pneumoniae (94.9%, 98.3%, 87.4% and 82.9% of isolates susceptible). Of the cephalosporins, cefepime was most effective against Escherichia coli, Proteus mirabilis and Enterobacter cloacae (99.2%, 96.3% and 95.2% of isolates susceptible, respectively) and cefoxitin against Klebsiella oxytoca and Klebsiella pneumoniae (98.6% and 95.6% of isolates susceptible). Carbapenems had excellent activity (> or =99.5% of all isolates). ESBL-production was confirmed with the ESBL-Etest and disk diffusion test in 1.3% of Escherichia coli isolates, 18.4% of Klebsiella pneumoniae, 12.6% of Klebsiella oxytoca and 5.3% of Proteus mirabilis isolates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aztreonam / pharmacology
  • Cephalosporins / pharmacology
  • Ciprofloxacin / pharmacology
  • Enterobacteriaceae / drug effects*
  • Enterobacteriaceae / enzymology
  • Enterobacteriaceae Infections / microbiology
  • Europe
  • Humans
  • Klebsiella / drug effects
  • Klebsiella / enzymology
  • Klebsiella / isolation & purification
  • Klebsiella Infections / microbiology
  • Microbial Sensitivity Tests
  • beta-Lactam Resistance*
  • beta-Lactamase Inhibitors
  • beta-Lactamases / biosynthesis
  • beta-Lactamases / metabolism*
  • beta-Lactams / metabolism
  • beta-Lactams / pharmacology*

Substances

  • Cephalosporins
  • beta-Lactamase Inhibitors
  • beta-Lactams
  • Ciprofloxacin
  • beta-Lactamases
  • Aztreonam